-
EP3281939
European procedure
Extract from the Register of European Patents
EP About this file: EP3281939
| EP3281939 - COMBINATION COMPRISING A STABLE CRYSTAL OF A 4-OXOQUINOLINE COMPOUND [Right-click to bookmark this link] | |||
| Former [2018/07] | METHOD OF PRODUCING STABLE CRYSTAL OF 4-OXOQUINOLINE COMPOUND | ||
| [2023/13] | Status | No opposition filed within time limit Status updated on 22.08.2024 Database last updated on 05.05.2025 | |
| Former | The patent has been granted Status updated on 15.09.2023 | ||
| Former | Grant of patent is intended Status updated on 28.03.2023 | ||
| Former | Examination is in progress Status updated on 23.07.2019 | ||
| Former | Request for examination was made Status updated on 17.08.2018 | ||
| Former | The application has been published Status updated on 12.01.2018 | Most recent event Tooltip | 22.08.2024 | No opposition filed within time limit | published on 25.09.2024 [2024/39] | Applicant(s) | For all designated states Japan Tobacco Inc. 1-1, Toranomon 4-chome Minato-ku Tokyo 105-6927 / JP | [2020/50] |
| Former [2018/07] | For all designated states Japan Tobacco Inc. 2-1 Toranomon 2-chome, Minato-ku Tokyo 105-8422 / JP | Inventor(s) | 01 /
SATOH, Motohide c/o Central Pharmaceutical Research Institute 1-1, Murasaki-cho, Takatsuki-shi Osaka, Osaka 569-1125 / JP | 02 /
MOTOMURA, Takahisa c/o Central Pharmaceutical Research Institute 1-1, Murasaki-cho, Takatsuki-shi Osaka, Osaka 569-1125 / JP | 03 /
MATSUDA, Takashi c/o Central Pharmaceutical Research Institute 1-1, Murasaki-cho, Takatsuki-shi Osaka, Osaka 569-1125 / JP | 04 /
KONDO, Kentaro c/o Central Pharmaceutical Research Institute 1-1, Murasaki-cho, Takatsuki-shi Osaka, Osaka 569-1125 / JP | 05 /
ANDO, Koji c/o Central Pharmaceutical Research Institute 1-1, Murasaki-cho, Takatsuki-shi Osaka, Osaka 569-1125 / JP | 06 /
MATSUDA, Koji c/o Central Pharmaceutical Research Institute 1-1, Murasaki-cho, Takatsuki-shi Osaka, Osaka 569-1125 / JP | 07 /
MIYAKE, Shuji c/o Central Pharmaceutical Research Institute 1-1, Murasaki-cho, Takatsuki-shi Osaka, Osaka 569-1125 / JP | 08 /
UEHARA, Hideto c/o Central Pharmaceutical Research Institute 1-1, Murasaki-cho, Takatsuki-shi Osaka, Okayama 569-1125 / JP | [2018/07] | Representative(s) | Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstrasse 3 81675 München / DE | [2018/07] | Application number, filing date | 17186674.2 | 19.05.2005 | [2018/07] | Priority number, date | JP20040150979 | 20.05.2004 Original published format: JP 2004150979 | [2018/07] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3281939 | Date: | 14.02.2018 | Language: | EN | [2018/07] | Type: | B1 Patent specification | No.: | EP3281939 | Date: | 18.10.2023 | Language: | EN | [2023/42] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 06.12.2017 | Classification | IPC: | A61K31/47, A61P31/18, C07D215/56 | [2023/13] | CPC: |
C07D215/56 (EP,KR,NO,US);
A61K31/47 (KR,NO);
A61P31/00 (EP);
A61P31/18 (EP,NO)
|
| Former IPC [2018/07] | C07D215/56 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2018/38] |
| Former [2018/07] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR | Extension states | AL | 13.08.2018 | BA | 13.08.2018 | HR | 13.08.2018 | LV | 13.08.2018 | MK | 13.08.2018 | YU | 13.08.2018 | Title | German: | KOMBINATION ENTHALTEND EINEN STABILEN KRISTALL EINER 4-OXOCHINOLIN-VERBINDUNG | [2023/13] | English: | COMBINATION COMPRISING A STABLE CRYSTAL OF A 4-OXOQUINOLINE COMPOUND | [2023/13] | French: | COMBINAISON COMPRENANT UN CRISTAL STABLE D'UN COMPOSÉ 4-OXOQUINOLINE | [2023/13] |
| Former [2018/07] | METHODE ZUR HERSTELLUNG EINES STABILEN KRISTALLS EINER 4-OXOCHINOLINVERBINDUNG | ||
| Former [2018/07] | METHOD OF PRODUCING STABLE CRYSTAL OF 4-OXOQUINOLINE COMPOUND | ||
| Former [2018/07] | MÉTHODE POUR PRÉPARATION D'UN CRISTAL STABLE DE COMPOSÉ 4-OXOQUINOLINE | Examination procedure | 17.08.2017 | Date on which the examining division has become responsible | 13.08.2018 | Examination requested [2018/38] | 22.11.2018 | Amendment by applicant (claims and/or description) | 26.07.2019 | Despatch of a communication from the examining division (Time limit: M04) | 18.09.2019 | Reply to a communication from the examining division | 27.09.2019 | Despatch of a communication from the examining division (Time limit: M06) | 03.09.2020 | Reply to a communication from the examining division | 24.03.2021 | Despatch of a communication from the examining division (Time limit: M06) | 28.12.2021 | Reply to a communication from the examining division | 11.01.2023 | Despatch of a communication from the examining division (Time limit: M04) | 22.02.2023 | Reply to a communication from the examining division | 29.03.2023 | Communication of intention to grant the patent | 31.08.2023 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time | 05.09.2023 | Fee for grant paid | 05.09.2023 | Fee for publishing/printing paid | 05.09.2023 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP05726243.8 / EP1636190 | EP12173572.4 / EP2514746 | Divisional application(s) | EP23203885.1 / EP4299563 | Opposition(s) | 19.07.2024 | No opposition filed within time limit [2024/39] | Request for further processing for: | The application is deemed to be withdrawn due to failure to fulfill actions required for granting the patent | 05.09.2023 | Request for further processing filed | 05.09.2023 | Full payment received (date of receipt of payment) Request granted | 12.09.2023 | Decision despatched | The application is deemed to be withdrawn due to failure to reply to the examination report | 28.12.2021 | Request for further processing filed | 28.12.2021 | Full payment received (date of receipt of payment) Request granted | 14.01.2022 | Decision despatched | The application is deemed to be withdrawn due to failure to reply to the examination report | 03.09.2020 | Request for further processing filed | 03.09.2020 | Full payment received (date of receipt of payment) Request granted | 14.09.2020 | Decision despatched | The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report | 22.11.2018 | Request for further processing filed | 22.11.2018 | Full payment received (date of receipt of payment) Request granted | 04.12.2018 | Decision despatched | Fees paid | Renewal fee | 27.11.2017 | Renewal fee patent year 03 | 27.11.2017 | Renewal fee patent year 04 | 27.11.2017 | Renewal fee patent year 05 | 27.11.2017 | Renewal fee patent year 06 | 27.11.2017 | Renewal fee patent year 07 | 27.11.2017 | Renewal fee patent year 08 | 27.11.2017 | Renewal fee patent year 09 | 27.11.2017 | Renewal fee patent year 10 | 27.11.2017 | Renewal fee patent year 11 | 27.11.2017 | Renewal fee patent year 12 | 27.11.2017 | Renewal fee patent year 13 | 23.05.2018 | Renewal fee patent year 14 | 22.05.2019 | Renewal fee patent year 15 | 31.03.2020 | Renewal fee patent year 16 | 21.05.2021 | Renewal fee patent year 17 | 30.03.2022 | Renewal fee patent year 18 | 30.03.2023 | Renewal fee patent year 19 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]US3472859 (LESHER GEORGE Y); | [A]WO9845269 (CENTRE NAT RECH SCIENT [FR], et al); | [E]EP1564210 (JAPAN TOBACCO INC [JP]) | by applicant | JPS567162B | JP2004150979 |